Armistice Capital »

Cervomed shares owned by Armistice Capital

Quarter-by-quarter ownership of Cervomed (CRVO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cervomed

Tip: Access up to 7 years of quarterly data

All positions including Cervomed held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cervomed by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $17M 734k 23.30

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Cervomed

RA Capital Management
Armistice Capital
Ikarian Capital
Adage Capital Partners GP
Soleus Capital Management
Crown Advisors Management
Boothbay Fund Management
CWM
Vanguard Group
BlackRock
Geode Capital Management
J. Goldman & Co
Point72 Asset Management
Hoey Investments
Cubist Systematic Strategies

View all funds holding Cervomed